Deepak Srivastava, MD, FAHA
President and Senior Investigator, Gladstone Institutes
Professor, University of California San Francisco
Deepak Srivastava, MD, is the President of the Gladstone Institutes, Director of the Roddenberry Stem Cell Center at Gladstone, and is also a Professor of Pediatrics and of Biochemistry & Biophysics at the University of California, San Francisco (UCSF) Medical Center. He holds the Robert W. and Linda Mahley Distinguished Professorship.
He received his BS from Rice University, MD from the University of Texas, trained in pediatrics at UCSF, and in pediatric cardiology at the Children’s Hospital of Harvard Medical School. Before joining Gladstone in 2005, Srivastava was a professor in the Departments of Pediatrics and Molecular Biology at the University of Texas Southwestern Medical Center in Dallas.
Dr. Srivastava’s laboratory discovered genetic bases for cardiac septal and valve defects and revealed complex signaling, transcriptional, and translational networks that regulate progenitor cells to adopt a cardiac cell fate and subsequently fashion a functioning heart. He has leveraged this knowledge to understand disease mechanisms using induced pluripotent stem cells, leading to new therapeutic candidates for heart disease. His laboratory also used developmental gene networks to reprogram resident cardiac fibroblasts directly into cardiomyocyte-like cells for regenerative purposes in the setting of heart failure.
Dr. Srivastava has founded two biotechnology companies to translate his work toward clinical trials, served as president of the International Society for Stem Cell Research, and is a member of the American Academy of Arts and Sciences and the National Academy of Medicine.